Safety and tolerability of biodegradable balloon spacers in patients undergoing radiotherapy for organ-confined prostate cancer

被引:0
|
作者
Topazio, Luca [1 ]
Narcisi, Federico [1 ]
Tana, Fabio [2 ]
Ciotta, Cosimo [2 ]
Iossa, Vincenzo [2 ]
Perna, Pasquale [2 ]
Chiaramonti, Francesco [2 ]
Romantini, Federico [1 ]
机构
[1] ASL Teramo, UOC Urol, Teramo, Italy
[2] Univ Aquila, Dept Life Hlth & Environm Sci, UOC Urol, PO Mazzini, Teramo, Italy
关键词
Prostate cancer; Spacer; Radiotherapy; Hypo-fractionated radiotherapy; RADIATION-THERAPY;
D O I
10.4081/aiua.2023.11156
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Radiotherapy is a common treatment for prostate cancer, and can be administered in various ways, including 3D conformal radio-therapy (3DCRT), intensity-modulated radiotherapy (IMRT) and hypo-fractionated radiation therapy. During treatment the gastrointestinal tract may be exposed to radiation and the rectal wall may be exposed to high doses of ionizing radiation, which can lead to rectal bleeding, ulcers or fistulas, and an increased risk of rectum cancer. Various strategies to minimize these complications have been developed in the last decade; one of the most promising is to use a rectal balloon to fixate the prostate gland during treatment or to inject biodegradable spacers between the prostate and rectum to reduce the rectal dose of radiation. Aim of our paper is to evaluate the safety and tolerability of spacers implantation. Materials and methods: From January 2021 to June 2022 all patients with a diagnosis of prostate cancer with unfavor-able/intermediate risk -poor prognosis and programmed hypo -fractionated radiation therapy were enrolled. In all patients biodegradable balloons spacers were placed posteriorly to the prostate to increase the separation between prostate and rectum. The duration of the procedure, observa-tion time, the appearance of early and late complications and their severity (according to Charlson comorbidity index) and tolerability of the device were recorded at the time of positioning and after 10 days. Results: 25 patients were enrolled in our study. Two patients (8%) underwent acute urine retention resolved with catheteri-zation and one patient (4%) developed a mild perineal hematoma that did not require any treatment. As regards late complications 1 patient (4%) developed hyperpyrexia (> 38 & DEG;C) the day after the procedure requiring continuation of antibiotic regimen. At T1 visit we recorded no medium-high grade complications. As for the tolerability of the device, it was optimal with no perineal discomfort or alterations of bowel function. Conclusions: Biodegradable balloon spacers appears to be safe and well tolerated and its positioning does not present any technical difficulties or risks of major complications.
引用
收藏
页码:35 / 38
页数:4
相关论文
共 50 条
  • [41] Patient selection essential in optimizing the benefit of radical prostatectomy for patients with organ-confined prostate cancer
    Resnick, Matthew J.
    Guzzo, Thomas J.
    ASIAN JOURNAL OF ANDROLOGY, 2011, 13 (06) : 789 - 790
  • [42] Adiponectin as a potential marker of prostate cancer progression:: Studies in organ-confined and locally advanced prostate cancer
    Housa, D.
    Vernerova, Z.
    Heracek, J.
    Prochazka, B.
    Cechak, P.
    Kuncova, J.
    Haluzik, M.
    PHYSIOLOGICAL RESEARCH, 2008, 57 (03) : 451 - 458
  • [43] Prognostic significance of a positive surgical margin in pathologically organ-confined prostate cancer
    Ahyai, Sascha A.
    Zacharias, Mario
    Isbarn, Hendrik
    Steuber, Thomas
    Eichelberg, Christian
    Koellermann, Jens
    Fisch, Margit
    Karakiewicz, Pierre I.
    Huland, Hartwig
    Graefen, Markus
    Chun, Felix K. -H.
    BJU INTERNATIONAL, 2010, 106 (04) : 478 - 483
  • [44] Photodynamic Therapy for Prostate Cancer-An Emerging Approach for Organ-Confined Disease
    Moore, Caroline M.
    Emberton, Mark
    Bown, Stephen G.
    LASERS IN SURGERY AND MEDICINE, 2011, 43 (07) : 768 - 775
  • [45] Surgical Management of Organ-Confined Prostate Cancer with Review of Literature and Evolving Evidence
    Goolam A.S.
    la Rosa A.H.-D.
    Manoharan M.
    Indian Journal of Surgical Oncology, 2018, 9 (2) : 225 - 231
  • [46] Patterns of failure after surgically radical resection for organ-confined prostate cancer
    Mickisch, GH
    Kranse, R
    AKTUELLE UROLOGIE, 2000, 31 : 70 - 73
  • [47] Genetic chances in clinically organ-confined prostate cancer by comparative genomic hybridization
    Fu, WT
    Bubendorf, L
    Willi, N
    Moch, H
    Mihatsch, MJ
    Sauter, G
    Gasser, TC
    UROLOGY, 2000, 56 (05) : 880 - 885
  • [48] Kurative Therapie bei organbegrenztem ProstatakarzinomCurative treatment of organ-confined prostate cancer
    Hubert John
    Urologie in der Praxis, 2019, 21 (1) : 33 - 35
  • [50] Prognostic consequences of the location of positive surgical margins in organ-confined prostate cancer
    Salomon, L
    Anastasiadis, AG
    Antiphon, P
    Levrel, O
    Saint, F
    De La Taille, A
    Cicco, A
    Vordos, D
    Hoznek, A
    Chopin, D
    Abbou, CC
    UROLOGIA INTERNATIONALIS, 2003, 70 (04) : 291 - 296